Bioinformatics Jobs UK 2026: Where Biology Meets Code

12 min read

Bioinformatics jobs UK 2026: salaries, top employers from Sanger to AstraZeneca, regulators and the skills hiring managers ask for.

The Short Answer

Bioinformatics jobs in the UK in 2026 sit at the intersection of genomics, statistics and software engineering, with hiring concentrated around the Wellcome Genome Campus at Hinxton, the Oxford-Cambridge arc and Stevenage. A junior bioinformatician typically earns £35,000–£50,000, mid-level roles pay £50,000–£75,000, senior positions reach £75,000–£110,000, and principal or lead bioinformaticians at commercial pharma can clear £110,000–£150,000. The biggest employers include the Wellcome Sanger Institute, EMBL-EBI, Genomics England, AstraZeneca and GSK, with growing demand from AI-for-drug-discovery scale-ups such as BenevolentAI and Healx. The Medicines and Healthcare products Regulatory Agency (MHRA) and UK Research and Innovation (UKRI) shape the regulatory and funding landscape. The clearest career signal in 2026 is the shift from descriptive genomics into AI-assisted target discovery, single-cell analysis and clinical pipeline engineering — the people writing Nextflow workflows for Genomics England or fine-tuning protein language models for AstraZeneca are commanding the strongest premiums.

What does a bioinformatician actually do in 2026?

A bioinformatician applies programming, statistics and biological domain knowledge to extract meaning from biological data — most often DNA, RNA or protein sequences, but increasingly imaging, single-cell and multi-omics datasets. In practice the day-to-day work looks closer to senior software engineering than wet-lab science. You will spend more time in Python or R, on the command line, in version control and on cloud HPC than in a laboratory.

Typical 2026 responsibilities include building and maintaining Nextflow or Snakemake pipelines for next-generation sequencing (NGS) data, running variant calling with BWA and GATK, processing single-cell RNA-seq with Seurat or Scanpy, running genome-wide association studies (GWAS), and integrating structural predictions from AlphaFold or protein language models such as ESM-2 into target discovery work. Senior bioinformaticians spend a meaningful share of their time on architecture: scaling pipelines on AWS or Google Cloud, agreeing data contracts with clinical teams, and reviewing junior code. The role has matured. In the UK in 2026, the strongest candidates can ship reproducible, peer-reviewed analysis pipelines as readily as they can interpret a Manhattan plot.

Who are the top UK employers hiring bioinformaticians?

UK bioinformatics hiring concentrates around a relatively small number of anchor institutions and a wider ring of scale-ups. If you can commute to Hinxton, Cambridge, Oxford, Stevenage or central London, the addressable market is large. Edinburgh and Manchester are smaller but credible alternatives.

The flagship academic and quasi-public employers are the Wellcome Sanger Institute (Hinxton, Cambridgeshire), EMBL-EBI (also at the Wellcome Genome Campus), Genomics England (London and Cambridge), the Francis Crick Institute (London), the Babraham Institute (Cambridge), the Roslin Institute (Edinburgh) and ELIXIR-UK partner sites. On the commercial side, AstraZeneca (Cambridge Biomedical Campus) and GSK (Stevenage and Cambridge) run the largest in-house computational biology functions, followed by Oxford Biomedica, Oxford Nanopore Technologies, Illumina UK and clinical genomics arms of NHS trusts via the NHS Genomic Medicine Service. The most-watched scale-ups in 2026 include BenevolentAI, Healx, Vaccitech, Mantle Bio and Etcembly, all of which lean heavily on machine learning over biological data. Hiring patterns in 2025 and into 2026 suggest the Sanger, Genomics England and AstraZeneca remain the three deepest pools of open headcount, with the Sanger consistently recruiting at both postdoctoral and senior staff scientist level.

How much do bioinformatics jobs in the UK pay?

Pay varies more by sector than by city. Commercial pharma at Cambridge and Stevenage pays the highest base salaries; academic and charity-funded institutes pay 15–25% less but offer stronger publication, training and pension benefits. The figures below reflect typical 2026 ranges observed across UK postings; individual offers vary with equity, bonus and on-call expectations.

Level

Years' experience

Typical UK base salary

Strongest-paying employers

Junior / Associate Bioinformatician

0–2

£35,000–£50,000

AstraZeneca, GSK, Illumina UK

Bioinformatician (mid)

2–5

£50,000–£75,000

AstraZeneca, Genomics England, BenevolentAI

Senior Bioinformatician

5–9

£75,000–£110,000

AstraZeneca, GSK, Healx

Principal / Lead Bioinformatician

9+

£110,000–£150,000+

AstraZeneca, GSK, BenevolentAI

Academic Postdoc

Post-PhD

£41,000–£55,000

Sanger, EMBL-EBI, Crick

Staff Scientist (Sanger band)

5–10

£55,000–£80,000

Wellcome Sanger Institute

Contract day rates exist but are less common than in pure software engineering. Where they appear — typically for short-term pipeline engineering at NHS genomics hubs or scale-ups — they sit between £450 and £750 per day inside IR35 and occasionally above £800 outside IR35 for niche specialisms such as single-cell or GPU-accelerated genomics. London-weighted public sector roles add a modest premium; Cambridge and Hinxton rarely do, despite the cost of living.

Where in the UK are the bioinformatics jobs?

Hinxton, Cambridge and Stevenage form the dominant cluster. The Wellcome Genome Campus at Hinxton — home to the Sanger and EMBL-EBI — is the single highest-density site in the country for bioinformatics roles. A short drive south is the Cambridge Biomedical Campus, where AstraZeneca's Discovery Centre, the MRC's units and several scale-ups co-locate. Stevenage, twenty minutes further south on the East Coast main line, is GSK's primary UK R&D site and home to the Stevenage Bioscience Catalyst, which incubates many of the smaller biotechs that hire computational staff.

Outside the Cambridge–Stevenage corridor, Oxford is the second cluster, anchored by Oxford Nanopore Technologies, Oxford Biomedica, Vaccitech and a deep university ecosystem. London carries Genomics England, the Crick, UCL and Imperial computational genomics groups, plus most of the AI-for-drug-discovery scale-ups. Edinburgh (the Roslin Institute and the University of Edinburgh's Institute of Genetics and Cancer) is the strongest hub outside the south-east, with particular strength in agricultural and animal genomics. Manchester has a smaller but growing presence around the NHS Genomic Medicine Service Alliance and the Health Innovation Manchester ecosystem. Remote and hybrid roles are common in 2026, but most employers expect at least one to three days a week on site, particularly where pipelines touch identifiable patient data.

What skills do UK employers actually ask for?

Job specs in 2026 are remarkably consistent. Hiring managers expect fluency in Python and at least working competence in R, comfort on the Linux command line, version control with Git, and the ability to write reproducible pipelines in Nextflow or Snakemake. NGS-specific tooling — BWA, STAR, GATK, samtools, bcftools — is treated as table stakes for any role touching sequencing data. Single-cell expertise (Seurat, Scanpy, scVI) is increasingly common and clearly priced into senior offers.

The differentiators in 2026 are cloud and machine learning. AWS or Google Cloud HPC experience, container orchestration (Docker and increasingly Singularity or Apptainer for HPC), and CI/CD for bioinformatics workflows are now expected at senior level. On the modelling side, familiarity with AlphaFold and ESM-2 protein language models has moved from "nice to have" to "expected" for any role in target discovery, antibody engineering or structural bioinformatics. Statistical genetics roles still demand strong GWAS, polygenic risk score and Mendelian randomisation skills. Clinical bioinformatics roles — particularly those touching the NHS Genomic Medicine Service — add ISO 15189, clinical validation and variant interpretation against ClinVar and ACMG guidelines to the list.

How does a bioinformatician differ from a computational biologist or genomic data scientist?

Job titles in this space overlap heavily and vary by employer, which makes pay benchmarking harder than it should be. The distinctions below are typical, not universal — read the job description carefully before assuming a title maps cleanly to a level.

  • Bioinformatician: pipeline-heavy, applied. Owns NGS workflows, variant calling, single-cell processing. Heavy Python, R, Nextflow, BWA, GATK.

  • Computational biologist: more theory and modelling. Mathematical models of biological systems, network biology, sometimes wet-lab adjacent. Heavier on R, MATLAB, simulation.

  • Genomic data scientist: machine learning over biological data. Deep learning on omics, protein language models, drug-target prediction. Heavier on PyTorch, JAX and feature engineering than on pipeline plumbing.

  • Clinical bioinformatician: works inside the NHS Genomic Medicine Service or a clinical genetics lab. Validates and reports variants under ISO 15189. Holds or works toward HCPC registration via the Scientist Training Programme (STP).

  • Wet-lab molecular biologist: complementary, not interchangeable. Designs and runs the experiments that produce the data the bioinformatician analyses. Most employers expect bioinformaticians to read protocols but not run them.

Salary differences across these titles are typically less than 10% at the same seniority. The bigger spread comes from sector — pharma vs. academia — and from whether the role carries machine-learning expectations.

Which UK regulators and bodies shape the field?

Several UK bodies influence what bioinformaticians can and cannot do, especially when patient data is involved. The Medicines and Healthcare products Regulatory Agency (MHRA) regulates medicines, medical devices and increasingly software as a medical device (SaMD) — a category that affects any bioinformatics pipeline used in clinical decision-making. The Human Fertilisation and Embryology Authority (HFEA) licenses embryo and gamete research, with clear implications for any computational work on pre-implantation genetic testing. The Health Research Authority (HRA) governs research ethics and approval for studies involving NHS patients or data.

UK Research and Innovation (UKRI), through the Biotechnology and Biological Sciences Research Council (BBSRC) and the Medical Research Council (MRC), is the dominant public funder of bioinformatics research and underwrites a large share of academic posts. ELIXIR-UK, the UK node of the European life-science data infrastructure, coordinates training and shared data resources. For clinical bioinformaticians, the NHS National School of Healthcare Science runs the Scientist Training Programme (STP) that leads to HCPC-registered Clinical Scientist (Bioinformatics) status. Knowing how these bodies fit together is a routine interview signal at Genomics England, the NHS Genomic Medicine Service and clinically adjacent commercial employers.

What is changing in UK bioinformatics in 2026?

Three shifts are reshaping hiring. First, Genomics England's follow-on programmes to the 100,000 Genomes Project — the Newborn Genomes Programme, the Diverse Data initiative and the maturing NHS Genomic Medicine Service — are pulling more bioinformaticians into clinical-grade pipeline work. Reproducibility, audit trails and clinical validation skills are commanding clear premiums. Second, AI-for-drug-discovery has moved from hype into hiring. AstraZeneca, GSK, BenevolentAI and Healx have all expanded computational headcount around protein language models, generative chemistry and target identification, and the boundary between "bioinformatician" and "ML engineer with a biology focus" is narrower than it was two years ago. Third, single-cell and spatial transcriptomics are now mainstream rather than frontier — most senior roles assume working knowledge of Seurat or Scanpy and at least exposure to spatial methods. Hedged conclusion: the centre of gravity is moving from sequence-level analysis toward integrated, ML-aware, clinically aware bioinformatics, and pay is following.

Frequently Asked Questions: Bioinformatics Jobs UK

Do I need a PhD to work in UK bioinformatics?

Not always, but a PhD opens significantly more doors. Most academic and many senior commercial posts assume a PhD in a relevant area — genetics, computational biology, statistics or computer science. At junior and mid-level commercial roles, particularly at AstraZeneca, GSK and the AI-first scale-ups, a strong MSc plus demonstrable pipeline and Python skills is increasingly acceptable. Clinical bioinformatics has its own route via the NHS STP.

Is Python or R more important for UK bioinformatics jobs?

Python is the dominant language for new pipelines, machine learning and cloud work in 2026, and most job specs list it first. R remains essential for statistical genetics, single-cell analysis with packages such as Seurat, and a great deal of legacy academic code. The honest answer is that mid and senior candidates are expected to be functional in both, with a clear primary language.

Can I move into bioinformatics from a software engineering background?

Yes, and the path is well-trodden, particularly into pipeline engineering and platform roles at Genomics England, the Sanger and the larger commercial employers. The harder transition is into roles requiring biological interpretation — variant calling decisions, single-cell cell-type annotation, target validation — where a few months of structured upskilling, ideally via a Wellcome-funded short course or an MSc conversion, is generally needed.

What is the typical UK bioinformatician salary at the Wellcome Sanger Institute?

Sanger pay bands in 2026 typically run £41,000–£55,000 for postdoctoral fellows, £55,000–£80,000 for staff scientists and senior bioinformaticians, and above £90,000 for group leaders and principal-level posts. Bands are published broadly but exact offers depend on experience and grant funding. Sanger pay sits below commercial pharma but above most UK universities.

Are remote bioinformatics jobs realistic in the UK in 2026?

Hybrid is the norm; fully remote is possible but less common. Most employers expect one to three days on site, particularly where work touches identifiable patient data or shared HPC environments. Fully remote roles do exist, often at AI-first scale-ups such as BenevolentAI and Healx, but they typically pay slightly less than equivalent on-site Cambridge or London roles.

Which UK location pays bioinformaticians the most?

Cambridge and Stevenage — driven by AstraZeneca and GSK — pay the highest commercial base salaries, with London close behind for AI-for-drug-discovery scale-ups. Hinxton (Sanger and EMBL-EBI) pays academic-equivalent salaries that are typically 15–25% below pharma at the same seniority but offer stronger publication track records.

Do UK bioinformatics roles require security clearance?

Most do not. Some Genomics England and NHS-facing roles require Baseline Personnel Security Standard (BPSS) or Security Check (SC) clearance because of access to identifiable patient data. Defence-adjacent biosecurity roles at Porton Down or Dstl can require higher clearances, but these are a small minority of the market.

How competitive is the UK bioinformatics market for graduates?

Competitive but not punishing. Junior posts at the Sanger, Crick and Babraham routinely attract well over a hundred applicants, but commercial junior roles at AstraZeneca, GSK and the scale-ups receive smaller, more self-selected fields. Graduates with a portfolio of reproducible analyses on GitHub, a published preprint and Nextflow or Snakemake exposure tend to be shortlisted quickly.

Summary: Is a Bioinformatics Career in the UK Right for You?

Bioinformatics in the UK in 2026 is a mature, well-paid and intellectually serious field for people who genuinely enjoy both biology and code. If you are drawn to the analytical side — pipelines, statistics, machine learning — and willing to learn enough biology to interpret your results responsibly, the demand at the Sanger, Genomics England, AstraZeneca, GSK and the AI-for-drug-discovery scale-ups is steady and the pay is competitive with general software engineering at senior level. If you prefer pure software or pure biology, adjacent fields will probably suit you better. The career signal worth taking seriously is this: the strongest 2026 candidates combine reproducible pipeline engineering with clinical or ML awareness, and the pay gap between them and pure pipeline staff is widening.

Looking for your next bioinformatics role? Browse the latest bioinformatics jobs UK at biotechnologyjobs.co.uk — the UK's specialist job board for biotechnology, genomics and life sciences careers.

Related Jobs

Spotlight

Director Biostatistics - Hematology

The Director, Biostatistics, leads the full scope of statistical contribution to a clinical development program, including life cycle management. The AD provides for statistical excellence in clinical development plans, trial planning, data analysis, interpretation and...

CSL logo

CSL

Spotlight

Senior Director, Global Clinical Program Lead, Immunoglobulin

CSL is transforming its R&D organization to accelerate innovation and create greater impact for patients. With a streamlined, project-led structure and a focus on collaboration, we're building a future-ready team that excels in dynamic biotech...

CSL logo

CSL

£56,000 – £65,000 pa On-site Permanent Clearance Required

Bioinformatics Engineer (we have office locations in Cambridge, Leeds & London)

The Bioinformatics Engineer will develop and scale knowledge platforms for the NHS Whole Genome Sequencing (WGS) Genomic Medicine Service, including PanelApp and CellBase. Responsibilities include building APIs, data models, and pipelines, collaborating with genomic data scientists, and ensuring clinical and biological accuracy in software. The role involves working in an agile team to deliver high-quality, clinically relevant genomic knowledge systems.

Genomics England logo

Genomics England

Cambridge, Cambridgeshire, United Kingdom

On-site Permanent

Senior Computational Biologist, Tooling

In this role, you will work on the Value Tech Tooling Team at the forefront of drug discovery, using massive data capabilities to develop and maintain robust data pipelines and analytical workflows. You will collaborate with a cross-functional team of computational biologists, engineers, and scientists to turn complex analyses into reusable tools and pipelines, accelerating the discovery of life-changing therapeutics.

Recursion logo

Recursion

London, United Kingdom

£37 – £46 pa On-site Contract

Postdoctoral Research Associate in Molecular Evolution and Functional Genomics (Fixed Term)

The role involves conducting interdisciplinary research at the intersection of molecular evolution, functional genomics, and machine learning. The postholder will manage their own research, contribute to graduate student development, and collaborate with researchers in computational biology, genetics, and applied mathematics.

University of Cambridge logo

University of Cambridge

Cambridge, South East England, United Kingdom

Hybrid Permanent

Protein Engineering and Innovation Scientist

This role involves leading the development and deployment of advanced in-silico protein engineering and design principles to generate complex reagents for drug discovery. You will collaborate with computational experts, protein expression teams, and external partners to design, generate, and test engineered proteins, contributing to scientific innovation and project delivery.

GSK logo

GSK

Stevenage, United Kingdom

On-site Permanent

Senior Director Translational Data Sciences

This role involves developing and executing a translational data strategy that bridges the gap between disease biology and clinical outcomes. The Senior Director will lead a team in integrating multi-omics data with AI-driven analytics, forming strategic partnerships, and ensuring clinical relevance in all analytical platforms.

GSK logo

GSK

Stevenage, United Kingdom

Hybrid Permanent

Principal Scientist

This role involves leveraging cutting-edge computational approaches to understand and treat cancer. You will analyze and integrate multi-omics and clinical data to characterize disease heterogeneity, model disease evolution, and investigate treatment response. Collaboration with experimental and clinical teams is key to translating complex data into actionable insights for drug discovery.

GSK logo

GSK

Stevenage, United Kingdom

Subscribe to Future Tech Insights for the latest jobs & insights, direct to your inbox.

By subscribing, you agree to our privacy policy and terms of service.

Hiring?
Discover world class talent.